Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
Authors
Keywords
-
Journal
Lancet Microbe
Volume 2, Issue 6, Pages e240-e249
Publisher
Elsevier BV
Online
2021-03-24
DOI
10.1016/s2666-5247(21)00025-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
- (2021) Catherine J. Reynolds et al. Science Immunology
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
- (2020) Paul Kellam et al. JOURNAL OF GENERAL VIROLOGY
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low Prevalence Communities and Reveal Durable Humoral Immunity.
- (2020) Tyler J. Ripperger et al. IMMUNITY
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
- (2020) Amin Addetia et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Scientific consensus on the COVID-19 pandemic: we need to act now
- (2020) Nisreen A Alwan et al. LANCET
- Sex differences in immune responses that underlie COVID-19 disease outcomes
- (2020) Takehiro Takahashi et al. NATURE
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- Humoral Immune Response to SARS-CoV-2 in Iceland
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
- (2020) Fan Wu et al. JAMA Internal Medicine
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
- (2020) Anita S. Iyer et al. Science Immunology
- Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
- (2020) Josée Perreault et al. BLOOD
- Th17 cell-derived IL-17 is dispensable for B cell antibody production
- (2012) Akiko Shibui et al. CYTOKINE
- IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production
- (2010) K. Maeda et al. BLOOD
- Interleukin-12 as an adjuvant for induction of protective antibody responses
- (2010) Dennis W. Metzger CYTOKINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started